Advertisement

Topics

Artificial Cell Technologies, Inc. Company Profile

08:06 EDT 22nd October 2017 | BioPortfolio

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypeptides. Our long term vision is to commercialize biotechnology applications for successively more sophisticated versions of an artificial bionanomachine: the artificial cell. ACT was founded to achieve this artificial cell vision by commercializing biomedical applications of our proprietary polypeptide nanostructure technology platform, starting with one of the simplest of human cells, the red blood cell. ACT’s technology platform includes proprietary methods for manufacturing custom-designed polypeptide films and microcapsules with controlled, tunable biological, chemical, and physical properties.

Location

5 Science Park Suite 13
New Haven
Connecticut
06511
United States of America

Contact

Phone: 203-772-3430
Fax: 203-567-8073


News Articles [2009 Associated News Articles listed on BioPortfolio]

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims ...

Why Do Doctors Resist Artificial Intelligence in the Clinic?

Experts discuss how artificial intelligence can support physicians, and how new technologies should be introduced into the clinic. Medscape

Formation of artificial cells with a skeletal support reinforcement to withstand pressure realized

A research group of Tokyo University of Agriculture and Technology, Tokyo Institute of Technology, Keio University and Tohoku University have successfully developed an artificial cytoskeletal structur...

Formation of artificial cells with a skeletal support reinforcement to withstand application realized

A research group of Tokyo University of Agriculture and Technology, Tokyo Institute of Technology, Keio University and Tohoku University have successfully developed an artificial cytoskeletal structur...

New tool for cell-free therapy based on artificial membrane vesicles

Scientists at Kazan Federal University's Institute of Fundamental Medicine and Biology, led by Professor Albert Rizvanov, have shown that artificial membrane vesicles generated by Cytochalasin B treat...

Study uses artificial intelligence to recognize heart patients at high risk of complications

The University of Tampere and TAYS Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart patients.

Photosynthesis Insight Could Yield Novel Solar Cell Design

ArticleA phenomenon occurring in photosynthesis could help engineers create a new type of artificial solar cell.

PubMed Articles [3638 Associated PubMed Articles listed on BioPortfolio]

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Enzymes as Key Features in Therapeutic Cell Mimicry.

Cell mimicry is a nature inspired concept that aims to substitute for missing or lost (sub)cellular function. This review focuses on the latest advancements in the use of enzymes in cell mimicry for e...

Enabling technologies in synthetic biology--DNA synthesis, assembly and editing.

Synthetic biology is an emerging discipline, which aims at creating artificial lives or remolding the present organisms to generate new features. To achieve these goals, synthetic biologists need to d...

Engineering the Future One Cell at a Time: Advancements in Cell-Based Techniques from Novel Three-Dimensional Cell Culture to a Bionic Kidney.

High-Definition Medicine.

The foundation for a new era of data-driven medicine has been set by recent technological advances that enable the assessment and management of human health at an unprecedented level of resolution-wha...

Clinical Trials [5892 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Artificial Shrinkage for Human Blastocyst Prior Vitrification

Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located ...

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

The purpose of this study is to assess and compare the safetyness and efficacy of pilocarpine drops versus artificial saliva as symptomatic treatment for dry mouth and dry eyes caused by...

The Visual Effect of an Investigational Artificial Tear in the Tear Layer.

The purpose of this study is to investigate how the addition of a new artificial tear product when applied to the tear layer affects contrast sensitivity and optical aberrations over time....

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Companies [2242 Associated Companies listed on BioPortfolio]

Artificial Cell Technologies, Inc.

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypep...

Kurzweil Technologies, Inc.

Kurzweil Technologies, Inc. (KTI) is a research and development company developing and marketing technologies in pattern recognition, artificial intelligence, evolutionary algorithms, signal processin...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artifici...

MyoPowers

MyoPowers Medical Technologies SA was founded by Dr Piergiorgio Tozzi, MD, of the University Hospital of Lausanne (CHUV), Switzerland and Professor Daniel Hayoz of the Cantonal Ho...

More Information about "Artificial Cell Technologies, Inc." on BioPortfolio

We have published hundreds of Artificial Cell Technologies, Inc. news stories on BioPortfolio along with dozens of Artificial Cell Technologies, Inc. Clinical Trials and PubMed Articles about Artificial Cell Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Artificial Cell Technologies, Inc. Companies in our database. You can also find out about relevant Artificial Cell Technologies, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record